(MTZ) MasTec - Overview
Stock: Communications, Energy, Utilities, Pipeline, Infrastructure
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 49.2% |
| Relative Tail Risk | -5.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.48 |
| Alpha | 66.27 |
| Character TTM | |
|---|---|
| Beta | 1.536 |
| Beta Downside | 1.486 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.01% |
| CAGR/Max DD | 0.66 |
Description: MTZ MasTec January 02, 2026
MasTec, Inc. (NYSE: MTZ) is a U.S.-based infrastructure construction firm that designs, builds, and maintains critical assets across communications, clean energy, power delivery, pipeline, and broader civil projects. Its service portfolio spans wireless and fiber-optic networks, renewable-energy generation facilities, natural-gas and water pipelines, electrical transmission and distribution systems, as well as roads, bridges, and rail structures.
The company’s revenue is heavily weighted toward the Communications segment (≈ 45 % of 2023 sales), reflecting ongoing 5G rollouts and broadband expansion, while Clean Energy and Infrastructure contributed roughly 20 % as demand for solar and wind projects accelerates. A key economic driver is the U.S. federal “Infrastructure Investment and Jobs Act,” which funds billions in grid modernization and broadband upgrades-directly feeding MasTec’s pipeline.
Operationally, MasTec reported a 2023 EBITDA margin of ~ 9.5 % and a free-cash-flow conversion rate of 75 %, underscoring its ability to fund growth without excessive leverage. The firm’s backlog stood at about $7 billion at year-end, providing visibility into future contract wins. Seasonal demand spikes for disaster-recovery services also add a non-cyclical revenue stream.
Given its diversified exposure to high-growth sectors like 5G, renewable energy, and grid resiliency, MasTec’s performance is closely tied to macro-level capital-spending trends and regulatory incentives. Investors should monitor the pace of 5G spectrum auctions and renewable-energy tax credit extensions as they could materially shift segment dynamics.
For a deeper, data-driven look at how MasTec’s valuation stacks up against peers, the ValueRay platform offers granular financial metrics and scenario analysis-worth a quick check if you’re building a thesis.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 331.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -7.17 > 1.0 |
| NWC/Revenue: 7.78% < 20% (prev 5.62%; Δ 2.15% < -1%) |
| CFO/TA 0.07 > 3% & CFO 644.7m > Net Income 331.1m |
| Net Debt (2.54b) to EBITDA (1.04b): 2.44 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.6m) vs 12m ago -0.34% < -2% |
| Gross Margin: 12.50% > 18% (prev 0.09%; Δ 1241 % > 0.5%) |
| Asset Turnover: 149.1% > 50% (prev 139.0%; Δ 10.14% > 0%) |
| Interest Coverage Ratio: 3.55 > 6 (EBITDA TTM 1.04b / Interest Expense TTM 171.9m) |
Altman Z'' 2.44
| A: 0.11 (Total Current Assets 4.31b - Total Current Liabilities 3.24b) / Total Assets 9.69b |
| B: 0.26 (Retained Earnings 2.56b / Total Assets 9.69b) |
| C: 0.07 (EBIT TTM 609.7m / Avg Total Assets 9.23b) |
| D: 0.39 (Book Value of Equity 2.53b / Total Liabilities 6.51b) |
| Altman-Z'' Score: 2.44 = A |
Beneish M -3.21
| DSRI: 1.06 (Receivables 3.70b/3.10b, Revenue 13.76b/12.18b) |
| GMI: 0.74 (GM 12.50% / 9.28%) |
| AQI: 0.91 (AQ_t 0.34 / AQ_t-1 0.37) |
| SGI: 1.13 (Revenue 13.76b / 12.18b) |
| TATA: -0.03 (NI 331.1m - CFO 644.7m) / TA 9.69b) |
| Beneish M-Score: -3.21 (Cap -4..+1) = AA |
What is the price of MTZ shares?
Over the past week, the price has changed by +7.77%, over one month by +9.65%, over three months by +31.78% and over the past year by +78.67%.
Is MTZ a buy, sell or hold?
- StrongBuy: 11
- Buy: 3
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MTZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 256 | -1.2% |
| Analysts Target Price | 256 | -1.2% |
| ValueRay Target Price | 348.8 | 34.6% |
MTZ Fundamental Data Overview February 03, 2026
P/E Forward = 29.4985
P/S = 1.3788
P/B = 6.2129
P/EG = 0.7832
Revenue TTM = 13.76b USD
EBIT TTM = 609.7m USD
EBITDA TTM = 1.04b USD
Long Term Debt = 2.20b USD (from longTermDebt, last quarter)
Short Term Debt = 314.4m USD (from shortTermDebt, last quarter)
Debt = 2.77b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.54b USD (from netDebt column, last quarter)
Enterprise Value = 21.51b USD (18.98b + Debt 2.77b - CCE 231.4m)
Interest Coverage Ratio = 3.55 (Ebit TTM 609.7m / Interest Expense TTM 171.9m)
EV/FCF = 51.64x (Enterprise Value 21.51b / FCF TTM 416.6m)
FCF Yield = 1.94% (FCF TTM 416.6m / Enterprise Value 21.51b)
FCF Margin = 3.03% (FCF TTM 416.6m / Revenue TTM 13.76b)
Net Margin = 2.41% (Net Income TTM 331.1m / Revenue TTM 13.76b)
Gross Margin = 12.50% ((Revenue TTM 13.76b - Cost of Revenue TTM 12.04b) / Revenue TTM)
Gross Margin QoQ = 13.56% (prev 12.29%)
Tobins Q-Ratio = 2.22 (Enterprise Value 21.51b / Total Assets 9.69b)
Interest Expense / Debt = 1.64% (Interest Expense 45.4m / Debt 2.77b)
Taxrate = 21.32% (45.1m / 211.6m)
NOPAT = 479.7m (EBIT 609.7m * (1 - 21.32%))
Current Ratio = 1.33 (Total Current Assets 4.31b / Total Current Liabilities 3.24b)
Debt / Equity = 0.89 (Debt 2.77b / totalStockholderEquity, last quarter 3.11b)
Debt / EBITDA = 2.44 (Net Debt 2.54b / EBITDA 1.04b)
Debt / FCF = 6.09 (Net Debt 2.54b / FCF TTM 416.6m)
Total Stockholder Equity = 2.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.59% (Net Income 331.1m / Total Assets 9.69b)
RoE = 11.17% (Net Income TTM 331.1m / Total Stockholder Equity 2.96b)
RoCE = 11.81% (EBIT 609.7m / Capital Employed (Equity 2.96b + L.T.Debt 2.20b))
RoIC = 9.17% (NOPAT 479.7m / Invested Capital 5.23b)
WACC = 10.27% (E(18.98b)/V(21.74b) * Re(11.58%) + D(2.77b)/V(21.74b) * Rd(1.64%) * (1-Tc(0.21)))
Discount Rate = 11.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.23%
[DCF Debug] Terminal Value 69.38% ; FCFF base≈651.8m ; Y1≈622.7m ; Y5≈601.9m
Fair Price DCF = 62.00 (EV 7.43b - Net Debt 2.54b = Equity 4.89b / Shares 78.9m; r=10.27% [WACC]; 5y FCF grow -5.86% → 2.90% )
EPS Correlation: 28.13 | EPS CAGR: 1.31% | SUE: -4.0 | # QB: 0
Revenue Correlation: 84.66 | Revenue CAGR: 23.29% | SUE: 0.27 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.79 | Chg30d=+0.014 | Revisions Net=+3 | Analysts=10
EPS next Year (2026-12-31): EPS=8.15 | Chg30d=-0.001 | Revisions Net=-2 | Growth EPS=+26.9% | Growth Revenue=+10.0%